PLAT and metabolic syndrome: Participants with higher PTX3 concentration generally had lower prevalence of metabolic syndrome, as well as favorable levels of various components associated with metabolic syndrome — including lower BMI, waist circumference, triglycerides, apoCIII and tPA, and higher levels of high-density lipoprotein (HDL) cholesterol.